This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What's Next For Stocks: 10% Pullback or Rolling Correction?
by Daniel Laboe
The enormous amount of sideline cash is still being put to work, with every marginal dip being bought right back up
Is First Trust NASDAQ100 Equal Weighted ETF (QQEW) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QQEW
Should Direxion NASDAQ100 Equal Weighted Index Shares (QQQE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for QQQE
ETF Strategies to Cheer the Dovish Fed Minutes
by Sweta Jaiswal, FRM
Here we discuss certain ETF strategies to help investors gain from optimism surrounding the Fed's dovish stance amid recovering U.S. economy from the pandemic-led slump.
Try These ETF Strategies to Play the Market Optimism for 2H21
by Sweta Jaiswal, FRM
Here we discuss certain ETF strategies to help investors gain from the optimism surrounding the expectations of a strong Wall Street run in the second half of 2021.
Is Invesco Dynamic Large Cap Growth ETF (PWB) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PWB
Should Direxion NASDAQ100 Equal Weighted Index Shares (QQQE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for QQQE
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
5 Equity ETFs That Sizzled Last Week Amid Market Rout
by Sweta Killa
U.S. equity funds claimed the top seven spots for the ETFs with the largest combined inflows of nearly $15 billion last week.
A Quick Guide to the 25 Cheapest ETFs
by Sweta Killa
Keeping the importance of expense ratio in mind, we have highlighted the 25 cheapest ETFs currently on the market and have AUM of more than $50 million.
ETF Strategies to Play the Drop in New US COVID-19 Cases
by Sweta Jaiswal, FRM
Here we discuss some ETF strategies that investors can play amid the upbeat outlook for the U.S. market.
Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DEF
Should Direxion NASDAQ100 Equal Weighted Index Shares (QQQE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for QQQE
5 Top-Ranked ETFs to Ride on a Booming Economy
by Sweta Killa
The American economy has been booming, pushing the U.S. stock indices to new highs.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
ETF Strategies to Play the US Market Optimism
by Sweta Jaiswal, FRM
Here we discuss some ETF strategies that investors can play amid the upbeat outlook for the U.S. market.
ETF Areas That Are Looking Attractive in April
by Sweta Jaiswal, FRM
Let's take a look at some ETF areas that are presenting some great investment opportunities for April considering the current market scenario.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
Don't Let Underperformance in Growth ETFs Fool You
by Sanghamitra Saha
Focus on the technology sector, rising virus cases, talks of a hike in capital gains tax and still-low rates should bring the growth investing back in favor.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
ETF Strategies to Gain From the Stimulus & Vaccine Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from optimism surrounding another trench of coronavirus-aid package and coronavirus vaccine development.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
Play These ETF Strategies to Ride the US Market Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from optimism surrounding the chances of another trench of coronavirus-aid package and improved coronavirus vaccine rollout.
Here's Why Growth ETFs are Ruling the 52-Week High Chart
by Sweta Jaiswal, FRM
As the coronavirus outbreak worsens, growth ETFs seem to be gaining investors favour in comparison to the value ETFs
ETF Strategies to Gain From US Market Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from the optimism surrounding the coronavirus vaccine development as the outbreak continues to aggravate.